HSA · registration DE0509148BD Difco™ Haemophilus Influenzae Antiserum Type b
SingaporeMicrobiologyClass BBecton, Dickinson and Company
Official record identity
- Registration number
- DE0509148
- Model name
- BD Difco™ Haemophilus Influenzae Antiserum Type b
- Model identifier
- 222361
- Registration date
- April 09, 2024
- Source update date
- February 17, 2025
Classification
- Risk class
- Class B
Official value: CLASS B
Published parties
- Product owner
- Becton, Dickinson and Company
- Registrant / registration holder
- BECTON DICKINSON HOLDINGS PTE. LTD.
Official description
BD Difco™ Haemophilus Influenzae Antisera are recommended for use in slide agglutination tests for serotyping Haemophilus influenzae.
Additional source fields
- Product owner address
- 7 Loveton Circle, Sparks, Maryland, 21152, United States
- Registrant address
- 10 COLLYER QUAY, #10-01, OCEAN FINANCIAL CENTRE, Singapore 049315
About this record
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.